These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12418935)

  • 81. Extreme weight gain in a youth with schizophrenia: risk/benefit considerations.
    Webster D; Devarajan S; Gallant J; Harris A; Kopala LC
    Schizophr Res; 2002 Jul; 56(1-2):187-9. PubMed ID: 12084432
    [No Abstract]   [Full Text] [Related]  

  • 82. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
    Harvey PD; Napolitano JA; Mao L; Gharabawi G
    Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hypothermia induced by risperidone and olanzapine in a patient with Prader-Willi syndrome.
    Phan TG; Yu RY; Hersch MI
    Med J Aust; 1998 Aug; 169(4):230-1. PubMed ID: 9734590
    [No Abstract]   [Full Text] [Related]  

  • 84. Safety profile assessment of risperidone and olanzapine in long-term care patients with dementia.
    Martin H; Slyk MP; Deymann S; Cornacchione MJ
    J Am Med Dir Assoc; 2003; 4(4):183-8. PubMed ID: 12837138
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications.
    Jerrell JM
    Schizophr Bull; 2002; 28(4):589-605. PubMed ID: 12795493
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics.
    Rabinowitz J; Lichtenberg P; Kaplan Z; Mark M; Nahon D; Davidson M
    Am J Psychiatry; 2001 Feb; 158(2):266-9. PubMed ID: 11156809
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
    Rascati KL; Johnsrud MT; Crismon ML; Lage MJ; Barber BL
    Pharmacoeconomics; 2003; 21(10):683-97. PubMed ID: 12828491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Long-term effectiveness of risperidone and olanzapine in resistant or intolerant schizophrenic patients. A mirror study.
    Søholm B; Lublin H
    Acta Psychiatr Scand; 2003 May; 107(5):344-50. PubMed ID: 12752030
    [TBL] [Abstract][Full Text] [Related]  

  • 89. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 91. Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.
    Bokszanska A; Martin G; Vanstraelen M; Holt G; Bouras N; Taylor D
    Int Clin Psychopharmacol; 2003 Sep; 18(5):285-91. PubMed ID: 12920389
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Global index of safety (GIS): a new instrument to assess drug safety.
    Sacristán JA; Gómez JC; Badía X; Kind P
    J Clin Epidemiol; 2001 Nov; 54(11):1120-5. PubMed ID: 11675163
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 94. Priapism associated with conventional and atypical antipsychotic medications: a review.
    Compton MT; Miller AH
    J Clin Psychiatry; 2001 May; 62(5):362-6. PubMed ID: 11411819
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Novel antipsychotics and severe hyperlipidemia.
    Meyer JM
    J Clin Psychopharmacol; 2001 Aug; 21(4):369-74. PubMed ID: 11476120
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Return of menstruation after switching from risperidone to olanzapine.
    Gazzola LR; Opler LA
    J Clin Psychopharmacol; 1998 Dec; 18(6):486-7. PubMed ID: 9864085
    [No Abstract]   [Full Text] [Related]  

  • 98. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
    Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
    Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients.
    Briken P; Nika E; Moritz S; Haasen C; Perro C; Yagdiran O; Naber D; Krausz M
    Schizophr Res; 2002 Oct; 57(2-3):311-3. PubMed ID: 12223264
    [No Abstract]   [Full Text] [Related]  

  • 100. Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients.
    Esel E; Basturk M; Saffet Gonul A; Kula M; Tayfun Turan M; Yabanoglu I; Sofuoglu S
    Psychoneuroendocrinology; 2001 Aug; 26(6):641-7. PubMed ID: 11403983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.